KEVIN MCGUINESS PLLC for TEVA PHARMACEUTICALS USA INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515, the Patent Reform Act of 2009
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Health Issues HCR
S. 369, the Preserve Access to Affordable Generics Act H.R. 1427, the Promoting Innovation and Access to Life-Saving Medicine Act
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Labor Issues/Antitrust/Workplace LBR
S. 639, the Preserve Access to Affordable Generics Act
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.